Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
68.60    -0.20 (-0.29%)
Bid:
68.50
Ask:
68.60
Spread: 0.10 (0.146%)
Market Cap: $42.67b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Issue of Equity

18 Dec 2017 13:59

RNS Number : 6762Z
Axis Bank Limited
18 December 2017
 

AXIS/CO/CS/726/2017-18

18th December 2017

 

Dear Sir,

SUB: ALLOTMENT OF EQUITY SHARES AND WARRANTS ON A PREFERENTIAL BASIS

 

REF: REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENT) REGULATIONS 2015.

 

This has reference to our letters AXIS/CO/CS/597/2017-18 dated 10th November 2017 and AXIS/CO/CS/685/2017-18 dated 8th December 2017, wherein we had informed you regarding outcome of the Board Meeting held on 10th November 2017 and outcome of the Extraordinary General Meeting of the Shareholders of the Bank held on 8th December 2017, respectively.

 

We are pleased to inform that the Committee of Whole-time Directors of the Bank at its meeting held today has pursuant to receipt of the consideration, approved the issuance and allotment of:

 

· 5,56,00,000 equity shares of face value of Rs. 2/- each (the "Investor 1 Equity Shares") to BC Asia Investments VII Limited (the "Investor 1"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 3,19,00,000 equity shares of face value of Rs. 2/- each (the "Investor 2 Equity Shares") to Integral Investments South Asia IV (the "Investor 2"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 4,00,00,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 3 Convertible Warrants") to BC Asia Investments III Limited (the "Investor 3"), on a preferential basis at a price of Rupees 565 per warrant.

 

· 59,98,000 equity shares of face value of Rs. 2/- each (the "Investor 4 Equity Shares") to New World Fund, Inc. (the "Investor 4"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 2,26,884 equity shares of face value of Rs. 2/- each (the "Investor 5 Equity Shares") to Capital Group New World Fund (LUX) (the "Investor 5"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 53,08,000 equity shares of face value of Rs. 2/- each (the "Investor 6 Equity Shares") to American Funds Insurance Series - International Fund (the "Investor 6"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 4,28,72,967 equity shares of face value of Rs. 2/- each (the "Investor 7 Equity Shares") to EuroPacific Growth Fund (the "Investor 7"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 5,65,899 equity shares of face value of Rs. 2/- each (the "Investor 8 Equity Shares") to American Funds Insurance Series - International Growth and Income Fund (the "Investor 8"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 27,86,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 4 Convertible Warrants") to Investor 4, on a preferential basis at a price of Rupees 565 per warrant.

 

· 1,05,385 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 5 Convertible Warrants") to Investor 5, on a preferential basis at a price of Rupees 565 per warrant.

 

· 24,66,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 6 Convertible Warrants") to Investor 6, on a preferential basis at a price of Rupees 565 per warrant.

 

· 2,28,57,142 equity shares of face value of Rs. 2/- each (the "Promoter Investor Equity Shares") to Life Insurance Corporation of India (the "Promoter Investor"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

Pursuant to the allotment of the said equity shares, the total issued and paid up share capital of the Bank has increased from Rs. 479,71,01,600 (239,85,50,800 equity shares of Rs. 2/- each) to Rs. 512,77,59,384 (256,38,79,692 equity shares of Rs. 2/- each).

 

Please note that the Equity Shares allotted on a preferential basis as aforesaid rank pari passu with the existing equity shares of the Bank, in all respects.

 

Further, the equity shares and convertible warrants shall be under lock-in for such period as prescribed under the SEBI (Issue of Capital and Disclosures Requirement) Regulations, 2009.

 

You are requested to take note the above and arrange to bring it to the notice of all concerned.

 

Thanking you.

 

Yours Sincerely,

For Axis Bank Limited

 

 

 

Girish V Koliyote

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEGGGAAPUPMGWR
Date   Source Headline
3rd Jul 20209:24 amRNSANNUAL REPORT INCLUDING THE NOTICE OF 26TH AGM
2nd Jul 20201:48 pmRNSCLOSURE OF AXIS BANK UK, SUBSIDIARY OF THE BANK
2nd Jul 20207:00 amRNSOutcome of Board Meeting for Raising of Funds
2nd Jul 20207:00 amRNSOutcome of Board Meeting - 26th AGM of the Bank
29th Jun 20204:34 pmRNSAPPOINTMENT OF DIRECTOR
29th Jun 20204:31 pmRNSBOARD MEETING TO CONSIDER RAISING OF CAPITAL.
29th Jun 20207:00 amRNSS & P Global Rating Action
15th Jun 20203:51 pmRNSRESIGNATION OF SHRI PRALAY MONDAL
1st Jun 20207:00 amRNSCLARIFICATION ON NEWS ITEM
29th Apr 20204:36 pmRNSReappointment of Director and Appointment of KMP
28th Apr 20201:29 pmRNSAUDITED FINANCIAL RESULTS OF THE BANK
28th Apr 20208:37 amRNSAGREEMENT WITH MAX FINANCIAL SERVICES LIMITED
27th Feb 20207:00 amRNSAPPOINTMENT OF SHRI PUNEET SHARMA AS CFO
20th Feb 202011:02 amRNSCONFIDENTIALITY AND EXCLUSIVITY ARRANGEMENT
27th Jan 202012:48 pmRNSQUARTERLY REPORTING - ALLOTMENT UNDER ESOP
22nd Jan 202012:45 pmRNS3rd Quarter Results
31st Dec 20197:00 amRNSCHANGE IN CRO & APPOINTMENT OF GROUP EXECUTIVE
12th Dec 201911:42 amRNSRESIGNATION OF SMT. USHA SANGWAN
6th Dec 201911:20 amRNSRESIGNATION OF JAIRAM SRIDHARAN - CFO OF THE BANK
22nd Oct 201912:46 pmRNSUNAUDITED FINANCIAL RESULTS OF THE BANK
22nd Oct 201912:01 pmRNSALLOTMENT OF EQUITY SHARES UNDER ESOP
22nd Oct 20197:00 amRNSCESSATION OF TENURE OF SHRI SOM MITTAL
30th Jul 201912:10 pmRNSUNAUDITED FINANCIAL RESULTS OF THE BANK
10th Jul 20193:55 pmRNSINTIMATION OF BOARD MEETING FOR RAISING OF FUNDS.
8th Jul 20192:22 pmRNSALLOTMENT OF EQUITY SHARES UNDER ESOP - QUARTERLY
5th Jul 20192:41 pmRNSBOARD MEETING OF AXIS BANK LIMITED
4th Jun 20193:06 pmRNSREVISION OF CREDIT RATING ASSIGNED BY FITCH RATING
23rd May 20191:05 pmRNSAppointment and Re-Appointment of Directors
25th Apr 20195:10 pmRNSOUTCOME OF THE BOARD MEETING OF AXIS BANK LIMITED
26th Mar 20192:04 pmRNSQUARTERLY ALLOTMENT OF EQUITY SHARES UNDER ESOP
13th Mar 20197:29 amRNSAppointment Of Shri Rakesh Makhija As The Chairman
30th Jan 201912:49 pmRNS3rd Quarter Results
31st Dec 201812:11 pmRNSCHANGE IN MANAGING DIRECTOR & CEO OF THE BANK
31st Dec 201811:55 amRNSQUARTERLY REPORTING ALLOT OF EQ SHARES UNDER ESOP
28th Dec 201811:40 amRNSSENIOR UNSECURED REDEEMABLE NCD
21st Dec 20181:25 pmRNSRETIREMENT OF V SRINIVASAN AS DMD OF THE BANK
10th Dec 20187:17 amRNSREAPPOINTMENT OF INDEPENDENT DIRECTORS
10th Dec 20187:05 amRNSAPPOINTMENT OF AMITABH CHAUDHRY AS THE MD & CEO
2nd Nov 20181:23 pmRNSRESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2018
2nd Nov 201812:43 pmRNSAppointment Of Amitabh Chaudhry As Designated MD
2nd Nov 201812:22 pmRNSDirectorate Change
17th Oct 20188:05 amRNSAXIS BANK RAISES USD 50 MILLION
8th Oct 20181:25 pmRNSDirector Declaration - CESSATION
5th Oct 20189:22 amRNSPublication of Offering Circular -1 October 2018
24th Sep 20182:07 pmRNSQUARTERLY REPORTING ALLOT OF EQ SHARES UNDER ESOP
24th Sep 20182:04 pmRNSNotice of Results
10th Sep 20187:05 amRNSRBI APPROVAL FOR APPOINTMENT OF MD & CEO
30th Jul 20182:03 pmRNS1st Quarter Results
27th Jun 20181:05 pmRNSQuarterly Reporting - Allotment of Equity shares
16th May 201810:36 amRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.